OraSure Sues To Freeze Prestige’s Purchase Of Wartner Wart Medicines
This article was originally published in The Tan Sheet
Executive Summary
OraSure Technologies is alleging breach of contract against Prestige Brands following the distributor's $31 mil. acquisition of the Wartner cryosurgical wart removal product line Sept. 25
You may also be interested in...
With Precision Tip, Dutch Firm Aims To Freeze Pain Out Of OTC Wart Treatment In US
Amsterdam firm TheOTCLab seeks a North American distributor or licensee for Dr. Yglo wart remover, a cryogenic product with a removable, precision tip for less painful application, says CEO Albert Swane.
OraSure–Prestige Brands arbitration
Prestige Brand's acquisition of the Wartner cryosurgical wart removal line breaches a non-compete provision between OraSure and Prestige, which markets OraSure's Compound W Freeze Off wart removal products, an arbitration panel states Oct. 23. The Wartner products compete directly in the domestic OTC market against Freeze Off, in violation of a clause in the parties' distribution agreement. The panel concludes OraSure is entitled to an award of its legal fees and share of arbitrators' costs and that all counterclaims asserted by Prestige Brands are rejected. Prestige Brands acquired Wartner in 2006 (1"The Tan Sheet" Oct. 2, 2006, p. 8)...
OraSure–Prestige Brands arbitration
Prestige Brand's acquisition of the Wartner cryosurgical wart removal line breaches a non-compete provision between OraSure and Prestige, which markets OraSure's Compound W Freeze Off wart removal products, an arbitration panel states Oct. 23. The Wartner products compete directly in the domestic OTC market against Freeze Off, in violation of a clause in the parties' distribution agreement. The panel concludes OraSure is entitled to an award of its legal fees and share of arbitrators' costs and that all counterclaims asserted by Prestige Brands are rejected. Prestige Brands acquired Wartner in 2006 (1"The Tan Sheet" Oct. 2, 2006, p. 8)...